CIK 0001860657 · <br>Emerging growth company
Allarity Therapeutics, Inc.
Sign in to watch- Ticker
- ALLR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 401-426-4664
- Business address
- 24 SCHOOL ST., 2ND FLOOR, BOSTON, MA, 02108
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Delisting notice
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
- 424B4 Offering Prospectus
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 8-K Event Material agreement · New debt or obligation · Delisting notice · Unregistered share sale
Page 12 of 21 · 403 filings